William Wilkie, Pharm.D.

Assistant Professor of Clinical Education

Prior to pharmacy school, Wilkie took advantage of many opportunities to strengthen his skills in research and teaching. As an analytical chemist in the Clinical Pharmacology Lab at Texas A&M’s Veterinary School, he was fortunate to have participated in several key research projects in collaboration with NASA, Bayer, and Pfizer. In addition to his duties as analytical chemist, he completed a master’s degree in toxicology. Following the completion of his master’s degree, he worked at the University of Connecticut as a research assistant and taught a special topics class in the pharmacy program. Later, Wilkie became certified to teach in the state of Texas where he taught high school chemistry, forensics, and health. Undoubtedly, these experiences became a springboard for life as an educator and researcher.

Wilkie’s residency training provided a strong clinical foundation. In addition to his clinical training, he had numerous longitudinal opportunities including lecturing at the College of Pharmacy and being an active member of several committees that are important to the hospital (pain management), department of pharmacy services (staffing), and to the residency program (recruitment).  Beyond the classroom, Wilkie enjoys mentoring students who are not only inquisitive but who are also curious about the pharmacy profession.  These experiences have allowed him to make an impact on patient care and provide direction for future colleagues in the pharmacy profession.

Core measure evaluation; liver disease


  • Wilkie WS, Schwieterman P. Strategies for the management of rheumatoid arthritis. Orthopedics. 2012; 35(2):125-130.


  • Boothe HW, Jones SA, Wilkie WS, Boeckh A, Stenstrom KK, Boothe DM. Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogs. Am J Vet Res. 2005; 66(10):1770-1774.
  • Morris JB, Wilkie WS, Shusterman DJ. Acute respiratory responses of the mouse to chlorine. Toxicol Sci. 2005; 83(2):380-387.


  • *Wilkie WS, Deep K, Brouse S, Davis G. Survey Says Patients are in Pain: An Analysis of HCAHPS Pain Scores. International Conference on Opioids. Boston, MA; June 2013.


  • *Wilkie WS, Deep K, Smith J, Brouse S, Davis G. Survey Says Patients are in Pain: An Analysis of HCAHPS Pain Scores—Project design and preliminary results. University Health Consortium. Las Vegas, NV; December 2012.
  • *Wilkie WS, Baker S, Weant K, Ratermann K. Antihypertensive Emergency in the ED. Great Lakes Pharmacy Resident Conference. West Lafayette, IN; April 2012.


  • Hanzelka KM, Rice TW, Garza JL, *Wilkie WS. Implementation of Early Goal Directed Therapy in the Emergency Center at a Cancer Institution.  2011 Texas Society of Health System Pharmacists Annual Seminar & Alcalde XXV Conference. San Antonio, TX; April 2011.
  • 2012 – 2013: ASHP-Accredited PGY2 Internal Medicine Residency; University of Kentucky HealthCare, Lexington, KY
  • 2011 – 2012: ASHP-Accredited PGY1 Pharmacy Practice Residency; University of Kentucky HealthCare, Lexington, KY
  • 2007 – 2011: Doctor of PharmacyUniversity of Houston College of Pharmacy, Houston, TX
  • 1998 – 2002: Masters of Science in Toxicology; Texas A&M University College of Veterinary Medicine, College Station, TX

Thesis: Pharmacokinetic Disposition of Lidocaine Following a Single Intravenous Dose in Healthy and Proteinuric Dogs.

  • 1992 – 1997: Bachelor of Science in Chemistry; Texas A&M University, College Station, TX; Undergrad research project: Nitric Oxide: Quantification by Acid Reduction and Chemiluminescence.